vs
3M（MMM）与Orchestra BioMed Holdings, Inc.（OBIO）财务数据对比。点击上方公司名可切换其他公司
3M的季度营收约是Orchestra BioMed Holdings, Inc.的195.0倍（$6.0B vs $30.9M）。Orchestra BioMed Holdings, Inc.净利率更高（20.2% vs 10.8%，领先9.4%）。Orchestra BioMed Holdings, Inc.同比增速更快（12120.2% vs 1.3%）。3M自由现金流更多（$2.0B vs $-2.3M）。过去两年Orchestra BioMed Holdings, Inc.的营收复合增速更高（606.2% vs -1.8%）
3M是美国知名跨国综合企业，业务覆盖工业、劳动者安全防护、消费品等多个领域，总部位于圣保罗郊区的枫木市。公司现有超6万款产品，涵盖胶粘剂、研磨材料、防火防护产品、个人防护装备、窗膜、车漆保护膜、电子连接绝缘材料、汽车养护产品、光学膜等品类。
Orchestra BioMed Holdings是一家临床阶段医疗科技企业，专注于开发针对心血管及其他高负担慢性疾病的新型循证治疗方案，核心业务覆盖介入心脏病学、慢病护理优化等领域，主要面向北美、欧洲市场运营，与头部医疗行业参与者开展合作。
MMM vs OBIO — 直观对比
营收规模更大
MMM
是对方的195.0倍
$30.9M
营收增速更快
OBIO
高出12118.9%
1.3%
净利率更高
OBIO
高出9.4%
10.8%
自由现金流更多
MMM
多$2.0B
$-2.3M
两年增速更快
OBIO
近两年复合增速
-1.8%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $6.0B | $30.9M |
| 净利润 | $653.0M | $6.2M |
| 毛利率 | 40.7% | 99.8% |
| 营业利润率 | 23.2% | 21.8% |
| 净利率 | 10.8% | 20.2% |
| 营收同比 | 1.3% | 12120.2% |
| 净利润同比 | -41.5% | 138.7% |
| 每股收益（稀释后） | $1.23 | $0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MMMOBIO
| Q1 26 | $6.0B | — | ||
| Q4 25 | $6.1B | $30.9M | ||
| Q3 25 | $6.5B | $861.0K | ||
| Q2 25 | $6.3B | $836.0K | ||
| Q1 25 | $6.0B | $868.0K | ||
| Q4 24 | $6.0B | $253.0K | ||
| Q3 24 | $6.3B | $987.0K | ||
| Q2 24 | $6.3B | $778.0K |
净利润MMMOBIO
| Q1 26 | $653.0M | — | ||
| Q4 25 | $577.0M | $6.2M | ||
| Q3 25 | $834.0M | $-20.8M | ||
| Q2 25 | $723.0M | $-19.4M | ||
| Q1 25 | $1.1B | $-18.8M | ||
| Q4 24 | $728.0M | $-16.2M | ||
| Q3 24 | $1.4B | $-15.4M | ||
| Q2 24 | $1.1B | $-16.0M |
毛利率MMMOBIO
| Q1 26 | 40.7% | — | ||
| Q4 25 | 33.6% | 99.8% | ||
| Q3 25 | 41.8% | 94.3% | ||
| Q2 25 | 42.5% | 94.5% | ||
| Q1 25 | 41.6% | 94.9% | ||
| Q4 24 | 51.7% | 77.1% | ||
| Q3 24 | 42.1% | 93.1% | ||
| Q2 24 | 42.9% | 94.3% |
营业利润率MMMOBIO
| Q1 26 | 23.2% | — | ||
| Q4 25 | 13.0% | 21.8% | ||
| Q3 25 | 22.2% | -2359.2% | ||
| Q2 25 | 18.0% | -2311.8% | ||
| Q1 25 | 20.9% | -2179.8% | ||
| Q4 24 | 12.2% | -6591.7% | ||
| Q3 24 | 20.9% | -1655.7% | ||
| Q2 24 | 20.3% | -2167.0% |
净利率MMMOBIO
| Q1 26 | 10.8% | — | ||
| Q4 25 | 9.4% | 20.2% | ||
| Q3 25 | 12.8% | -2419.0% | ||
| Q2 25 | 11.4% | -2316.1% | ||
| Q1 25 | 18.7% | -2160.7% | ||
| Q4 24 | 12.1% | -6385.4% | ||
| Q3 24 | 21.8% | -1562.9% | ||
| Q2 24 | 18.3% | -2054.0% |
每股收益（稀释后）MMMOBIO
| Q1 26 | $1.23 | — | ||
| Q4 25 | $1.07 | $0.28 | ||
| Q3 25 | $1.55 | $-0.40 | ||
| Q2 25 | $1.34 | $-0.50 | ||
| Q1 25 | $2.04 | $-0.49 | ||
| Q4 24 | $1.33 | $-0.42 | ||
| Q3 24 | $2.48 | $-0.41 | ||
| Q2 24 | $2.07 | $-0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.7B | $106.5M |
| 总债务越低越好 | $10.9B | $15.0M |
| 股东权益账面价值 | $3.3B | $53.6M |
| 总资产 | $35.4B | $114.9M |
| 负债/权益比越低杠杆越低 | 3.29× | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资MMMOBIO
| Q1 26 | $3.7B | — | ||
| Q4 25 | — | $106.5M | ||
| Q3 25 | — | $95.8M | ||
| Q2 25 | — | $33.9M | ||
| Q1 25 | — | $49.9M | ||
| Q4 24 | — | $66.8M | ||
| Q3 24 | — | $66.9M | ||
| Q2 24 | — | $65.2M |
总债务MMMOBIO
| Q1 26 | $10.9B | — | ||
| Q4 25 | $12.6B | $15.0M | ||
| Q3 25 | $12.6B | $15.0M | ||
| Q2 25 | $13.1B | $15.0M | ||
| Q1 25 | $13.5B | $15.0M | ||
| Q4 24 | $13.0B | $15.0M | ||
| Q3 24 | $13.2B | — | ||
| Q2 24 | $13.1B | — |
股东权益MMMOBIO
| Q1 26 | $3.3B | — | ||
| Q4 25 | $4.7B | $53.6M | ||
| Q3 25 | $4.6B | $43.7M | ||
| Q2 25 | $4.3B | $295.0K | ||
| Q1 25 | $4.5B | $16.9M | ||
| Q4 24 | $3.8B | $33.0M | ||
| Q3 24 | $4.6B | $46.2M | ||
| Q2 24 | $3.9B | $44.1M |
总资产MMMOBIO
| Q1 26 | $35.4B | — | ||
| Q4 25 | $37.7B | $114.9M | ||
| Q3 25 | $37.6B | $104.8M | ||
| Q2 25 | $38.0B | $42.8M | ||
| Q1 25 | $40.0B | $59.1M | ||
| Q4 24 | $39.9B | $76.2M | ||
| Q3 24 | $40.9B | $75.3M | ||
| Q2 24 | $43.4B | $72.4M |
负债/权益比MMMOBIO
| Q1 26 | 3.29× | — | ||
| Q4 25 | 2.68× | 0.28× | ||
| Q3 25 | 2.72× | 0.34× | ||
| Q2 25 | 3.06× | 50.85× | ||
| Q1 25 | 3.02× | 0.89× | ||
| Q4 24 | 3.40× | 0.46× | ||
| Q3 24 | 2.84× | — | ||
| Q2 24 | 3.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-2.3M |
| 自由现金流经营现金流 - 资本支出 | $2.0B | $-2.3M |
| 自由现金流率自由现金流/营收 | 33.6% | -7.4% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | -0.36× |
| 过去12个月自由现金流最近4个季度 | $3.7B | $-49.5M |
8季度趋势，按日历期对齐
经营现金流MMMOBIO
| Q1 26 | — | — | ||
| Q4 25 | $1.6B | $-2.3M | ||
| Q3 25 | $1.8B | $-14.6M | ||
| Q2 25 | $-954.0M | $-15.5M | ||
| Q1 25 | $-79.0M | $-16.6M | ||
| Q4 24 | $1.8B | $-13.5M | ||
| Q3 24 | $-1.8B | $-13.7M | ||
| Q2 24 | $1.0B | $-10.2M |
自由现金流MMMOBIO
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.3B | $-2.3M | ||
| Q3 25 | $1.5B | $-14.9M | ||
| Q2 25 | $-1.2B | $-15.6M | ||
| Q1 25 | $-315.0M | $-16.7M | ||
| Q4 24 | $1.5B | $-13.6M | ||
| Q3 24 | $-2.0B | $-13.8M | ||
| Q2 24 | $752.0M | $-10.3M |
自由现金流率MMMOBIO
| Q1 26 | 33.6% | — | ||
| Q4 25 | 21.8% | -7.4% | ||
| Q3 25 | 23.6% | -1725.9% | ||
| Q2 25 | -18.3% | -1861.4% | ||
| Q1 25 | -5.3% | -1927.2% | ||
| Q4 24 | 25.4% | -5392.9% | ||
| Q3 24 | -32.3% | -1394.9% | ||
| Q2 24 | 12.0% | -1325.6% |
资本支出强度MMMOBIO
| Q1 26 | — | — | ||
| Q4 25 | 4.0% | 0.1% | ||
| Q3 25 | 3.3% | 36.0% | ||
| Q2 25 | 3.3% | 4.1% | ||
| Q1 25 | 4.0% | 12.9% | ||
| Q4 24 | 4.8% | 41.9% | ||
| Q3 24 | 3.9% | 6.9% | ||
| Q2 24 | 4.3% | 13.8% |
现金转化率MMMOBIO
| Q1 26 | — | — | ||
| Q4 25 | 2.74× | -0.36× | ||
| Q3 25 | 2.11× | — | ||
| Q2 25 | -1.32× | — | ||
| Q1 25 | -0.07× | — | ||
| Q4 24 | 2.50× | — | ||
| Q3 24 | -1.30× | — | ||
| Q2 24 | 0.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MMM
| Safety and Industrial business segment | $2.9B | 49% |
| Transportation and Electronics business segment | $1.8B | 31% |
| Consumer business segment | $1.1B | 19% |
| Corporate | $121.0M | 2% |
OBIO
暂无分部数据
